Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
United States
University of California, San Francisco, San Francisco, California Emory University, Atlanta, Georgia University of Michigan, Ann Arbor, Michigan Children's Hospital of Philadelphia, Philadelphia, Pennsylvania Netherlands
Princess Máxima Center for Pediatric Oncology, Utrecht Switzerland
The University Children's Hospital in Zurich, Zurich, Canton of Zurich